An Informational Meeting for Patients with Clinical Research Ambassadors
The Medical Research Agency, in collaboration with Clinical Research Ambassadors, invites you to participate in a free informational meeting (online) designed with patients in mind. The purpose of the meeting is to disseminate and promote knowledge about clinical research and to raise awareness about the process of developing new drugs and medical technologies. It is dedicated to all individuals interested […]
The MULDiMediC project has been recommended for funding under Competition ABM/2023/2
We are very pleased to announce that the Project “MULDiMediC” has been recommended for funding under the Competition ABM/2032/2 (Competition for the creation and development of Regional Digital Medicine Centers). Our Competition proposal received 285 points, was granted funding of nearly PLN 30 million and was ranked fifth in the ranking among 19 of all […]
Competition for companies to develop or adapt medical devices, including digital solutions, for the needs of emergency medicine, treatment, and rehabilitation of injuries sustained in combat medicine, mass events, and disasters
On June 12, 2023, the Medical Research Agency (ABM) published the Regulations for the “Competition for companies to develop or adapt medical devices, including digital solutions, for the needs of emergency medicine, treatment, and rehabilitation of injuries sustained in combat medicine, mass events, and disasters”. The main objective of the Competition is to increase the chances […]
Open Competition for Non-commercial Epidemiological Research
On May 16, 2023, the Medical Research Agency (ABM) published the Regulations for the “Open Competition for Non-commercial Epidemiological Research on Multimorbidity”. The main objective of the competition is to study the frequency of multimorbidity, assess its impact on the health status of the Polish population, evaluate existing risk factors, utilize tools for trend modeling, and […]
The COMBO-UC trial project has been recommended for funding under Competition ABM/2022/3
We are very pleased to announce that the Project “Comparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis – the head to head COMBO-UC trial” has been recommended for funding under the Competition ABM/2022/3 (Competition for non-commercial clinical trials or research experiments – head to head studies). Our Competition proposal received 131 […]
Competition ABM/2023/1
On March 10, 2023, the Medical Research Agency (ABM) published the Competition Regulations for: “Competition for non-commercial clinical trials or research experiments – head to head – edition II”. The main objective of the Competition is to develop new standards for treatment, diagnosis, rehabilitation or prevention through ongoing non-commercial clinical trials or research experiments, as […]
List of One Hundred 2022
Puls Medycyny has published the List of One Hundred 2022, a list of people who have had the greatest impact on the development of Polish medicine and a positive influence on the health care system in Poland. We would like to congratulate all the laureates, and we are particularly pleased to see the recognition of our Scientific […]
An informational meeting for patients in clinical trials
There is an open recruitment for an informational meeting dedicated to patients to be held by the Clinical Trials Ambassadors. The meeting is scheduled to take place remotely on 15.03.2023 at 18.00-19.30. Please go to the site and detailed information using the link below: LINK The main aim of the event is to increase patients’ awareness […]
The schedule of ABM Competitions for 2023
The Medical Research Agency has announced the schedule of Competitions for the coming year. The total funds allocated for the planned Competitions in 2023 is PLN 750 million. It is planned to launch 5 Competitions in the following thematic areas: More details available here: https://abm.gov.pl/pl/aktualnosci/1904,Harmonogram-konkursow-ABM-na-2023-r.html
Competition ABM/2022/6
The Medical Research Agency has published the Regulations for the Competition dedicated to the entrepreneurs: for the development of targeted or personalised medicine based on nucleic acid and small molecule compounds (ABM/2022/6). If you collaborate with the private sector entities which conduct activities defined within the Competition frames, you are encouraged to contact the Clinical […]